Posted on

Close of Mylan/Upjohn tie-up extended to H2

Citing delays associated with the COVID-19 pandemic, Mylan N.V. (NASDAQ:MYL) and Pfizer (NYSE:PFE) now expect the merger between Mylan and Upjohn to be finalized in H2 instead of next quarter.
Mylan’s extraordinary general meeting of shareholders to approve the marriage has been rescheduled to June 30 from April 27, …

Read More